Skip to main content

GELS · Gelteq Ltd

Track GELS — free
$0.86 -0.04 (-4.57%)
Market Cap
$9.64M
Shares
10.71M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.90 Open$0.81 Day$0.77–0.90 52W close$0.39–1.60 Avg vol 30d4.8M Short int13K · 0.1% float · 1.0d Short vol26% DataOct 2024–Sep 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
Trailing 12 months
Net income (TTM)
−$3.41M
Trailing 12 months
Revenue growth YoY
Year over year
Operating margin
-3,317.7%
Trailing 12 months
P / E (TTM)
Trailing earnings
FCF yield
TTM · current market cap
Return on invested capital
Trailing 12 months
Net cash
Latest balance sheet
Dividend yield
Trailing 12 months
Shares change YoY
Year over year · more shares
Price change (1Y)
-6.3%
Trailing year
Short interest
0.1%
Latest settlement · 1.0 days to cover
View all 114 metrics

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Buy Momentum Strong Sentiment Bullish Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 14.5 · calm Equity put/call 0.58
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +22%
above
Price vs 50-day avg +51%
above
RSI (14) 76
overbought
MACD trend Positive
52-week position 42%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Strong
1-month return +61%
trailing
6-month return +13%
trailing
YTD return +13%
this year
Relative strength −3%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow Accumulating
+20% holders QoQ · +3 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.12% of float · ▼ -62.6% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
6 holders — mid 1-yr range
Squeeze score 33
low risk · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 228%
annualized · 1-yr
Max drawdown −76%
past year
ATR 11.1%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Buy
1 · 3 · 3
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+22% Bullish
Price vs 50-day avg
+51% Bullish
RSI (14)
76 Bearish
MACD trend
Positive Bullish
52-week position
42% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow Accumulating
+20% holders QoQ · +3 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.12% of float · ▼ -62.6% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
6 holders — mid 1-yr range
Price context
position in its 52-week range
Range low $0 Now $1 · 42% Range high $2
vs 200-day avg +22% vs 50-day avg +51%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Drug Manufacturers - Specialty & Generic — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
GELS
Gelteq Ltd
this stock
$9.64M +12.5% 0.1%
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
$66.37B 0.0%
TAK
Takeda Pharmaceutical Co Ltd
$58.92B +18.3% 0.1%
GALDY
Galderma Group AG/ADR
$45.51B -5.8% 0.0%
TEVA
Teva Pharmaceutical Industries Ltd
$42.37B +16.5% +4.3% 59.6 3.1%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
6
% held
1.0%
Net QoQ
+47.6K sh
Top holder
TWO SIGMA SECURITIES, LLC
Held Float
View
Short & Settlement
Short Interest Falling
Shares short
12.7K
Days to cover
1.0d
Change
-21.2K sh
View
Short Volume
Short vol %
26%
As of
Sep 4, 2026
Short Total
View
Fails to Deliver
FTD shares
1.6K
Value
$921
As of
Aug 7, 2026
View
Off-Exchange
Off-exchange %
66.9%
Week of
Jul 27, 2026
Off-exch Lit
View
Filings
SEC Filings
Latest
6-K
Filed
Jul 6, 2026
This year
5
View

Performance

5D 20D 120D MTD YTD
GELS +61.9% +61.3% +12.5% +64.9% +12.5%
SPY +0.1% -0.4% +15.1% +0.4% +12.9%
vs SPY +61.8% +61.7% -2.6% +64.5% -0.4%
Key facts CIK 1920092 CUSIP Q3978B109 13F (30d) 5 filings 5 filers Visit website Investor relations